Precision BioSciences, Inc. Common Stock (DTIL) is a publicly traded Healthcare sector company. As of September 29, 2026, DTIL trades at $6.33 with a market cap of $171.68M and a P/E ratio of -4.85. DTIL moved +1.44% today. Year to date, DTIL is +50.00%; over the trailing twelve months it is +23.32%. Its 52-week range spans $3.53 to $9.62. Analyst consensus is buy with an average price target of $60.00. Rallies surfaces DTIL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for DTIL, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $6.33 |
| Market Cap | $171.68M |
| P/E Ratio | -4.85 |
| EPS | $-1.28 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.62 |
| 52-Week Low | $3.53 |
| Volume | 205 |
| Avg Volume | 0 |
| Revenue (TTM) | $45.05M |
| Net Income | $-52.73M |
| Gross Margin | 0.00% |
1 analysts cover DTIL: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $60.00.